Combination GLP-1 receptor agonist and SGLT2 inhibitor therapy versus GLP-1 receptor agonist monotherapy on arrhythmia outcomes in non-diabetic obese patients: A real-world time-dependent analysis

International Journal of Cardiology Cardiovascular Risk and Prevention · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles